InvestorsHub Logo
Followers 58
Posts 10092
Boards Moderated 1
Alias Born 09/21/2016

Re: nidan7500 post# 458426

Tuesday, 05/07/2024 8:58:43 AM

Tuesday, May 07, 2024 8:58:43 AM

Post# of 459967

believe that Anavex may submit a Marketing Authorisation Application to the European Medicine Agency, EMA for blarcamesine related to the treatment of Alzheimer’s disease by or before summer 2024 and possibly obtain EMA approval to start selling blarcamesine in the EU by or before the end of 2024.



Any informed opinions about What are odds on this timing actually happening...?
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AVXL News